Actinium Pharmaceuticals, Inc. financial data

Symbol
ATNM on NYSE
Industry
Pharmaceutical Preparations
Location
100 Park Ave., 23 Rd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Cactus Ventures, Inc. (to 3/29/2013)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 969 % -7.48%
Debt-to-equity 113 % +18.2%
Return On Equity -57 % -75.8%
Return On Assets -45.4 % +13.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.2M shares +6.12%
Common Stock, Shares, Outstanding 31.2M shares +12.9%
Entity Public Float 226M USD +12.9%
Common Stock, Value, Issued 31K USD +10.7%
Weighted Average Number of Shares Outstanding, Basic 30.1M shares +13%
Weighted Average Number of Shares Outstanding, Diluted 30.1M shares +13%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 30M USD -22.3%
General and Administrative Expense 12.1M USD -9.41%
Operating Income (Loss) -42.1M USD +18.9%
Nonoperating Income (Expense) 3.88M USD +25%
Net Income (Loss) Attributable to Parent -38.2M USD +21.7%
Earnings Per Share, Basic -1.27 USD/shares +30.6%
Earnings Per Share, Diluted -1.27 USD/shares +30.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 72.9M USD -4.92%
Other Assets, Current 357K USD +58%
Assets, Current 74.5M USD -4.8%
Property, Plant and Equipment, Net 364K USD -33.8%
Operating Lease, Right-of-Use Asset 1.69M USD -26.4%
Assets 76.9M USD -5.58%
Liabilities, Current 8.15M USD -4.07%
Contract with Customer, Liability, Noncurrent 35M USD 0%
Operating Lease, Liability, Noncurrent 984K USD -36.6%
Liabilities 44.1M USD -2.05%
Retained Earnings (Accumulated Deficit) -376M USD -11.3%
Stockholders' Equity Attributable to Parent 32.8M USD -9.95%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 57.2M USD -16.9%
Liabilities and Equity 76.9M USD -5.58%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.37M USD +51.1%
Net Cash Provided by (Used in) Financing Activities 14.8M USD +1818%
Net Cash Provided by (Used in) Investing Activities -11K USD +85.5%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 31.2M shares +12.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.4M USD -148%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 73.2M USD -4.89%
Deferred Tax Assets, Valuation Allowance 102M USD +12.2%
Operating Lease, Liability 1.55M USD
Payments to Acquire Property, Plant, and Equipment 11K USD -85.5%
Lessee, Operating Lease, Liability, to be Paid 1.65M USD
Operating Lease, Liability, Current 569K USD +7.36%
Lessee, Operating Lease, Liability, to be Paid, Year Two 643K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 630K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 100K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 380K USD
Deferred Tax Assets, Operating Loss Carryforwards 47.9M USD +14.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 380K USD
Operating Lease, Payments 153K USD +2%
Additional Paid in Capital 409M USD +9.26%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%